DelistedThis company is no longer listed on the London Stock Exchange.
Bivictrix Therapeutics plc
Financial Health
Going concern
Material uncertainty
Recent RNS announcements
No recent announcements
Annual Reports
14 Aug 2026
Annual Report and Accounts (to 2025-12-31)
Directors (7)
MK
Michael Kauffman, M.D., Ph.DNon-Executive Chairman
–
TJ
Tiffany Jane ThornFounder & Chief Executive Officer
5 yrs 5 mos
PV
Petter Veiby, Ph.DNon-Executive Director
–
DM
Dr Michael Glen KauffmanDirector
4 yrs 10 mos
AL
Alison Lindsay HalsallSecretary
3 yrs 1 mos
Company details
BiVictriX is a biotech firm that is quickly gaining ground by utilizing a unique method to create cancer treatments that are both safer and more efficient.
Michael Kauffman, M.D., Ph.DNon-Executive Chairman
–
TJ
Tiffany Jane ThornFounder & Chief Executive Officer
5 yrs 5 mos
PV
Petter Veiby, Ph.DNon-Executive Director
–
DM
Dr Michael Glen KauffmanDirector
4 yrs 10 mos
AL
Alison Lindsay HalsallSecretary
3 yrs 1 mos
Company details
BiVictriX is a biotech firm that is quickly gaining ground by utilizing a unique method to create cancer treatments that are both safer and more efficient.